Top compounds associated with response to CHD2


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1 CTRPv2 pan-cancer AAC -0.052 0.1
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.063 0.1
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.056 0.1
mRNA myriocin CTRPv2 pan-cancer AAC -0.13 0.1
mRNA TGX221 CTRPv2 pan-cancer AAC -0.06 0.1
mRNA vorapaxar CTRPv2 pan-cancer AAC -0.061 0.1
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.054 0.1
mRNA KU-55933 GDSC1000 pan-cancer AAC 0.057 0.1
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.1
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.1
Download CSV